BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2871146)

  • 1. Neuroendocrine cells in colorectal adenomas.
    Van den Ingh HF; Van den Broek LJ; Verhofstad AA; Bosman FT
    J Pathol; 1986 Mar; 148(3):231-7. PubMed ID: 2871146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophil and argentaffin cells in adenomas of the colon and rectum.
    Iwashita A; Watanabe H; Enjoji M
    Fukuoka Igaku Zasshi; 1989 Feb; 80(2):114-24. PubMed ID: 2473950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of protein p53 in the adenoma-colorectal carcinoma sequence].
    Gafà R; Lanza G
    Pathologica; 1998 Aug; 90(4):351-6. PubMed ID: 9793394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large bowel adenomas: markers of risk and endpoints.
    Baron JA
    J Cell Biochem Suppl; 1996; 25():142-8. PubMed ID: 9027611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin.
    Sentani K; Oue N; Noguchi T; Sakamoto N; Matsusaki K; Yasui W
    Pathol Int; 2010 Apr; 60(4):291-7. PubMed ID: 20403031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The occurrence and clinicopathological significance of serotonin immunoreactive cells in large bowel carcinoma.
    Arends JW; Wiggers T; Verstijnen K; Bosman FT
    J Pathol; 1986 Jun; 149(2):97-102. PubMed ID: 3525789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
    Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
    Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
    Risio M; Candelaresi G; Rossini FP
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of adenomas.
    Day DW; Morson BC
    Major Probl Pathol; 1978; 10():43-57. PubMed ID: 359942
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine.
    Boer K; Helinger E; Helinger A; Pocza P; Pos Z; Demeter P; Baranyai Z; Dede K; Darvas Z; Falus A
    Eur J Cell Biol; 2008 Apr; 87(4):227-36. PubMed ID: 18258331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
    Cardillo MR; Yap E
    J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argyrophil cells in adenomas of familial polyposis coli.
    Okayasu I; Hatakeyama S; Iwama T; Utsunomiya J
    Bull Tokyo Med Dent Univ; 1981 Mar; 28(1):1-5. PubMed ID: 6938330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer location and synchronous adenomas.
    Slater G; Fleshner P; Aufses AH
    Am J Gastroenterol; 1988 Aug; 83(8):832-6. PubMed ID: 3394686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study.
    Cardillo MR; Yap EP
    Arch Anat Cytol Pathol; 1996; 44(5-6):241-9. PubMed ID: 9339011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paneth cell differentiation in colonic epithelial neoplasms: evidence for the role of the Apc/beta-catenin/Tcf pathway.
    Joo M; Shahsafaei A; Odze RD
    Hum Pathol; 2009 Jun; 40(6):872-80. PubMed ID: 19269007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanism pertinent to mucosal invasion in sporadic colonic adenomas.
    Rubio CA
    Anticancer Res; 2004; 24(3b):2033-6. PubMed ID: 15274396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
    Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study.
    Mueller J; Mueller E; Hoepner I; Jütting J; Bethke B; Stolte M; Höfler H
    J Pathol; 1996 Nov; 180(3):259-65. PubMed ID: 8958802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine cells in colonic tumors.
    Bosman FT
    Mod Pathol; 1992 May; 5(3):312-4. PubMed ID: 1495936
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroendocrine cells in non-endocrine tumors: what does it mean?
    Bosman FT
    Verh Dtsch Ges Pathol; 1997; 81():62-72. PubMed ID: 9474856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.